Skip to main content
Premium Trial:

Request an Annual Quote

Zeptosens to Design Custom Protein Arrays for GlaxoSmithKline

NEW YORK, April 26 (GenomeWeb News) - Zeptosens said today that it will supply GlaxoSmithKline with custom-made protein microarrays.

 

Under the agreement, Zeptosens, located in Witterswil, Switzerland, will provide GSK with protein microarrays designed using GSK's analytes and binding reagents.

 

GSK already owns a Zeptosens protein microarray analysis system, which is based on planar waveguide technology.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.